Home
Storia in 1 fonti
A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
Raccontata da
statnews.com
Timeline cronologica
- ·
In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a competitive billion-dollar market.
- ·
A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.